Latvia vs Libya: Antiretroviral therapy coverage
Latvia
52.0%
in 2024
Libya
50.0%
in 2023
Latvia rank
117th
Libya rank
120th
Antiretroviral therapy coverage over time
- Latvia
- Libya
How they compare
Latvia currently reports 52.0% against 50.0% in Libya, a difference of 2.0%.
The two have swapped places 1 time across 24 shared years of data; in 2000 it was Libya ahead.
Latvia ranks 117th and Libya ranks 120th of 143 countries.
Across the 3 decades both report, Latvia averaged higher in 1 and Libya in 2.
Head to head by decade
| Decade | Latvia | Libya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.2% | 21.1% | 17.9% | Libya |
| 2010s | 22.0% | 55.5% | 33.5% | Libya |
| 2020s | 49.2% | 49.0% | 0.2% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Latvia or Libya?
- Latvia, at 52.0% against 50.0% in Libya as of 2024.
- What is the difference in antiretroviral therapy coverage between Latvia and Libya?
- 2.0%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Libya?
- 24 years are reported by both, from 2000 to 2023.
- How do Latvia and Libya rank globally for antiretroviral therapy coverage?
- Latvia ranks 117th and Libya ranks 120th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.